<DOC>
	<DOC>NCT01147224</DOC>
	<brief_summary>The aim of the study is to evaluate the efficacy of Alvesco in patients with persistent asthma including or excluding allergic components over 3 months, especially in the spring season. Alvesco will be inhaled by a metered-dose inhaler. The study will provide further data on safety and tolerability of Alvesco .</brief_summary>
	<brief_title>ATEM (Alvesco Non-interventional Study)</brief_title>
	<detailed_description />
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Ciclesonide</mesh_term>
	<criteria>Main Asthma with or without allergic components Main Hypersensitive to compounds of Alvesco Other criteria as defined in the Summary of Product Characteristics, Chapter 4.3</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Asthma</keyword>
	<keyword>Allergy</keyword>
	<keyword>Ciclesonide</keyword>
	<keyword>Alvesco</keyword>
	<keyword>Inhaled steroids</keyword>
</DOC>